"Cell type X increased after treatment" is one of the most commonly reported single-cell findings and one of the easiest to manufacture. Here is the same dataset (GEO GSE96583 (Kang et al. 2018) — 8 donors, control vs IFN-β, 6 h stimulation) analysed both ways.
| Cell type | Control | IFN-β | adj. p — pooled cells | adj. p — per donor |
|---|---|---|---|---|
| B cells | 9.73% | 9.66% | 1 | 1 |
| CD14+ Monocytes | 24.54% | 22.53% | 0.023 ✓ | 0.31 |
| CD4 T cells | 40.46% | 41.06% | 1 | 1 |
| CD8 T cells | 8.49% | 7.71% | 0.032 ✓ | 0.12 |
| Dendritic cells | 1.75% | 2.05% | 1 | 1 |
| FCGR3A+ Monocytes | 6.25% | 7.14% | 0.019 ✓ | 0.44 |
| Megakaryocytes | 1.58% | 1.43% | 1 | 1 |
| NK cells | 7.2% | 8.43% | 0.002 ✓ | 0.62 |
Pooling every cell into one contingency table treats 24,673 cells as 24,673 independent observations. At that sample size a difference of one or two percentage points becomes "significant" — which is how 4 cell types end up reported as changed. Testing the same question at the level that actually varies, the donor, with each person compared against themselves, none of them survives.
In this experiment, yes — and that is the point. PBMCs stimulated for six hours in vitro have no opportunity to change composition; the cells were counted, not recruited. A method that reports composition shifts in an experiment where none can occur will also report them where none exist in your data. The honest deliverable here is a negative result, stated clearly, with the effect sizes shown so a reader can judge for themselves.